These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2625740

  • 1. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
    Yoshida K, Saka M, Kaneko Y, Kubota K, Hirao Y, Okajima E, Ishida M, Kihouin K, Motomiya Y.
    Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1171-7. PubMed ID: 2625740
    [Abstract] [Full Text] [Related]

  • 2. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P, Jacquot C, Capron L, Frydman MO, Vignon D, Aiach M.
    Thromb Haemost; 1987 Jun 03; 57(3):263-8. PubMed ID: 3660328
    [Abstract] [Full Text] [Related]

  • 3. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y.
    Fukuoka Igaku Zasshi; 1991 Nov 03; 82(11):576-85. PubMed ID: 1774013
    [Abstract] [Full Text] [Related]

  • 4. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure.
    Langley PG, Keays R, Hughes RD, Forbes A, Delvos U, Williams R.
    Hepatology; 1991 Aug 03; 14(2):251-6. PubMed ID: 1860682
    [Abstract] [Full Text] [Related]

  • 5. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ, Samson D, Stirling Y, Seghatchian MJ.
    Thromb Haemost; 1985 Jun 24; 53(3):314-9. PubMed ID: 4049307
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.
    Suzuki T, Ota K, Naganuma S, Koshikawa S, Hirasawa Y, Nakagawa S, Otsubo O, Akizawa T.
    Semin Thromb Hemost; 1990 Oct 24; 16 Suppl():46-54. PubMed ID: 1962904
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of heparin in uremic patients during hemodialysis].
    Cullmann W, Glöckner WM, Müller N.
    Fortschr Med; 1981 Mar 26; 99(12):410-2. PubMed ID: 7227936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A study of antithrombin systems during heparin therapy].
    Boneu B, Immaculato F, Sie P, Caranobe C, Chamontin B, Guittard J.
    Nouv Presse Med; 1982 Oct 16; 11(41):3043-6. PubMed ID: 6183640
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

  • 16. Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis.
    Winter M, Needham J, Mackie I, Cameron JS.
    Clin Nephrol; 1984 Dec 28; 22(6):307-13. PubMed ID: 6441660
    [Abstract] [Full Text] [Related]

  • 17. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V, Triolo L, De Martini D, Ferrelli R, Mori R, Leone G.
    J Lab Clin Med; 1987 May 28; 109(5):550-5. PubMed ID: 3572202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.